REGULATORY LANDSCAPE Archives

Anti-Obesity Drugs – Pharma Companies Race to Grab a Bite of the Pie

16/07/2025by EOS Intelligence

For many years, bariatric surgery has been the go-to option for people struggling with obesity and obesity-induced conditions. However, for the last couple of years, another easier option has become...

Estonia’s Rise as Europe’s Fintech Powerhouse

01/12/2024by EOS Intelligence

Estonia, a small Baltic country with a population of 1.4 million, is in the news for all the right reasons: its burgeoning fintech sector. With a market size of €15.2 billion...

Open Banking Sparking a Wave of Innovation in Financial Services

21/11/2024by EOS Intelligence

The adoption of open banking is leading to innovation across financial solutions such as account-to-account payments (A2A), personal finance management (PFM) apps, embedded finance, and banking-as-a-service (BaaS) by enabling real-time...

New Directions in Alzheimer’s Diagnostics: Will Blood Tests Replace CSF and PET?

30/09/2024by EOS Intelligence

Around three-fourths of dementia cases continue to remain undiagnosed even though the incidence of Alzheimer’s disease (AD) is rapidly growing across the globe. AD affects about 60-80% of dementia patients...

Phase 3 Drug Candidates – A Ray of Hope in Alzheimer’s Disease Bleak Treatment Landscape?

26/09/2024by EOS Intelligence

Many biopharmaceutical companies, such as AriBio, Annovis Bio, Athira Pharma, Cassava Sciences, and Alzheon, specializing in treating neurodegenerative diseases, are developing drugs for Alzheimer’s disease (AD) that are currently in...

What’s Fueling Asia’s Drive to Develop Wholesale CBDCs?

22/08/2024by EOS Intelligence

The emergence of Central Bank Digital Currencies (CBDCs) has become a central focus in the global financial space, as it offers the potential for revolutionary shifts in how the world...

Charting the RegTech Journey: Navigating Consolidation

09/07/2024by EOS Intelligence

RegTech, short for regulatory technology and often categorized as a subset of fintech, emerged in 2015. The RegTech industry was fragmented, with numerous small players targeting specific niches within the...

IRA: Are Patients Winning at the Cost of the US Pharma Sectoral Growth?

20/06/2024by EOS Intelligence

The market reaction to the US Inflation Reduction Act of 2022 is mostly mixed. It is expected to change the pharma industry dynamics in terms of the competitive positioning and...

Who We Are

Connect With Us

Work With EOS